Taoka Chemical Co., Ltd. (JP:4113)
:4113
Top Page
Taoka Chemical Co., Ltd.
(4113)
Select Model
Select Model
Rating:69Neutral
Price Target:
¥1,064.00
▼(-13.92% Downside)
Action:DowngradedDate:01/30/26
The score is driven primarily by strong financial performance (profitability and cash flow) and supportive valuation (low P/E and solid dividend yield). These positives are partially offset by weak technicals, with the share price in a clear downtrend despite oversold momentum signals.
Positive Factors
Cash Flow Strength
Consistent strong operating cash flow and positive free cash flow provide durable internal funding for capex, R&D, dividends and debt reduction. This cash generation capacity increases resilience to demand cyclicality and supports strategic reinvestment over coming quarters.
Negative Factors
Declining Equity Ratio
The slight decline in equity ratio, while modest, signals a change in financing mix that could reduce the capital cushion if persistent. Over several months this trend can increase sensitivity to leverage, borrowing costs and limit flexibility during industry downturns.
Read all positive and negative factors
Positive Factors
Negative Factors
Cash Flow Strength
Consistent strong operating cash flow and positive free cash flow provide durable internal funding for capex, R&D, dividends and debt reduction. This cash generation capacity increases resilience to demand cyclicality and supports strategic reinvestment over coming quarters.
Read all positive factors
Taoka Chemical Co., Ltd. (4113) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥13.93B
Dividend Yield3.23%
Average Volume (3M)39.40K
Price to Earnings (P/E)16.5
Beta (1Y)1.17
Revenue Growth13.09%
EPS Growth89.45%
CountryJP
Employees458
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)18.77
Shares Outstanding14,440,000
10 Day Avg. Volume29,300
30 Day Avg. Volume39,396
Financial Highlights & Ratios
PEG Ratio0.14
Price to Book (P/B)0.91
Price to Sales (P/S)0.57
P/FCF Ratio5.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)160.5
Revenue Forecast (FY)¥39.00B
Taoka Chemical Co., Ltd. Business Overview & Revenue Model
Company Description
Taoka Chemical Company, Limited manufactures and sells various chemicals in Japan and internationally. It provides raw material for resists; one-component epoxy-based adhesives for bonding various materials; cyanoacrylate-based instant adhesives; ...
How the Company Makes Money
Taoka Chemical generates revenue primarily through the manufacture and sale of chemical products to business customers. Its earnings are driven by (1) product sales volume and pricing across its chemical portfolio, and (2) cost management (e.g., r...
Taoka Chemical Co., Ltd. Financial Statement Overview
Summary
Income Statement
75
Positive
Balance Sheet
70
Positive
Cash Flow
80
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 30.89B | 29.93B | 28.54B | 30.17B | 32.37B | 32.06B |
| Gross Profit | 5.77B | 5.49B | 4.58B | 4.00B | 6.32B | 7.22B |
| EBITDA | 2.93B | 3.37B | 2.54B | 1.91B | 4.18B | 5.51B |
| Net Income | 1.63B | 1.48B | 820.48M | 310.65M | 2.06B | 2.62B |
Balance Sheet | ||||||
| Total Assets | 30.71B | 30.41B | 29.83B | 31.14B | 32.50B | 28.04B |
| Cash, Cash Equivalents and Short-Term Investments | 1.18B | 1.18B | 972.01M | 853.40M | 718.63M | 4.33B |
| Total Debt | 1.33B | 1.75B | 2.37B | 4.49B | 974.58M | 721.78M |
| Total Liabilities | 12.04B | 11.91B | 12.62B | 14.57B | 15.75B | 12.81B |
| Stockholders Equity | 18.68B | 18.50B | 17.21B | 16.57B | 16.75B | 15.24B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.97B | 2.50B | -2.84B | -3.37B | 3.16B |
| Operating Cash Flow | 0.00 | 4.37B | 3.63B | 1.48B | -1.33B | 5.22B |
| Investing Cash Flow | 0.00 | -1.42B | -1.14B | -4.34B | -2.08B | -2.09B |
| Financing Cash Flow | 0.00 | -997.00M | -2.39B | 3.00B | -273.53M | -680.45M |
Taoka Chemical Co., Ltd. Technical Analysis
Neutral
1236.00
Price Trends
1052.73
Negative
1142.62
Negative
1216.35
Negative
Market Momentum
-29.95
Negative
47.74
Neutral
77.02
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4113, the sentiment is Neutral. The current price of 1236 is above the 20-day moving average (MA) of 949.61, above the 50-day MA of 1052.73, and above the 200-day MA of 1216.35, indicating a neutral trend. The MACD of -29.95 indicates Negative momentum. The RSI at 47.74 is Neutral, neither overbought nor oversold. The STOCH value of 77.02 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:4113.
Taoka Chemical Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥81.58B | 6.04 | ― | 3.04% | 1.57% | -33.97% | |
71 Outperform | ¥19.13B | 4.28 | ― | 3.61% | 8.85% | 110.05% | |
69 Neutral | ¥13.93B | 16.46 | ― | 3.23% | 13.09% | 89.45% | |
66 Neutral | ¥8.49B | 2.66 | ― | 2.84% | 37.67% | -117.29% | |
62 Neutral | ¥16.21B | 9.21 | ― | 2.78% | 1.30% | -5.03% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
* Basic Materials Sector Average
JP:4113
Taoka Chemical Co., Ltd.
972.00
96.35
11.00%
JP:4116
Dainichiseika Color & Chemicals Mfg.Co., Ltd.
1,128.00
496.53
78.63%
JP:4119
Nippon Pigment Company, Limited
5,410.00
2,615.99
93.63%
JP:4409
Toho Chemical Industry Company, Limited
760.00
196.05
34.76%
JP:4635
Tokyo Printing Ink Manufacturing Co., Ltd.
1,414.00
751.13
113.31%
Taoka Chemical Co., Ltd. Corporate Events
Taoka Chemical Cuts Full-Year Earnings Forecast on Weak Fine Chemicals Demand
Jan 28, 2026
Taoka Chemical has revised downward its full-year consolidated earnings forecast for the fiscal year ending March 31, 2026, cutting projected net sales from ¥35.5 billion to ¥33.0 billion and reducing expected operating, ordinary, and at...
Taoka Chemical Posts Strong Nine-Month Earnings and Plans Higher Dividend for FY2025
Jan 28, 2026
Taoka Chemical reported consolidated net sales of ¥25.38 billion for the nine months ended December 31, 2025, up 13.4% year on year, with operating profit rising 26.4% to ¥1.77 billion and profit attributable to owners of parent increasi...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.